Evolving spectrum:: The pathogenesis of endometriosis

Clinical Obstetrics and Gynecology

Volumn 53, Issue 2, 2010, Pages 379-388

  Jensen, Jani R ^a   Coddington III, Charles C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Endometriosis; Immunology; Metaplasia; Neoplasia; Pathogenesis; Retrograde menstruation

Indexed keywords

AROMATASE; ATORVASTATIN; CELL ADHESION MOLECULE; CYCLOOXYGENASE 2; ESTROGEN; FENOFIBRATE; IMMUNOMODULATING AGENT; INTEGRIN; MATRIX METALLOPROTEINASE; PROSTAGLANDIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; VASCULOTROPIN;

CELL ADHESION; CELL GROWTH; CELL INVASION; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; CHORIOALLANTOIS; ECTOPIC TISSUE; ENDOMETRIOSIS; ENDOMETRIUM CELL; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GROWTH INHIBITION; HUMAN; NEUTROPHIL; NONHUMAN; REVIEW; STROMA; ENDOMETRIUM; FEMALE; LYMPHATIC SYSTEM; MENSTRUATION DISORDER; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PERITONEAL DISEASES; PREGNANCY;

ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; LYMPHATIC SYSTEM; MENSTRUATION DISTURBANCES; NEOVASCULARIZATION, PATHOLOGIC; PERITONEAL DISEASES; PREGNANCY;

EID: 77951961062     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3181db7b84     Document Type: Review

References (65)

1. Simpson JL, Elias S, Malinak LR, et al. Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol. 1980;137:327-331.
2. Cullen TS. Adenomyoma of the round ligament. Johns Hopkins Hosp Bull. 1896;11:576.
3. Russell WW. Aberrant portions of the Mullerian duct found in an ovary. Johns Hopkins Hosp Bull. 1899;10:8.
4. Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into peritoneal cavity. Am J Obstet Gynecol. 1927;14:422-469.
5. D'Hooghe TM, Debrock S. Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons. Hum Reprod Update. 2002;8:84-88.
6. Williams TJ. Endometriosis. 6th ed. Philadelphia: J. B. Lippincott Co; 1985:257-286.
7. Ferguson BR, Bennington JL, Haber SL. Histochemistry of mucosubstances and histology of mixed Mullerian pelvic lymph node glandular inclusions. Evidence for histogenesis by Mullerian metaplasia of coelomic epithelium. Obstet Gynecol. 1969;33:617-625.
8. Sasson IE, Taylor HS. Stem cells and the pathogenesis of endometriosis. Ann N Y Acad Sci. 2008;1127:106-115.
9. Halban J. Hysteroadenosis metastica (die lymphogene genes dersog. adenofibromatosis hetertopica). Wein Klin Wochenschr. 1924;37:1205.
10. Sampson JA. Metastatic or embolic endometriosis due to menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol. 1927;3:93-109.
11. Bulun S. Endometriosis. N Engl J Med. 2009;360:268-279.
12. Hornung D, Ryan IP, Chao VA, et al. Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. J Clin Endocrinol Metab. 1997;82:1621-1628.
13. Kao LC, Germeyer A, Tulac S, et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology. 2003;144:2870-2881.
14. Osteen KG, Bruner KL, Sharpe-Timms KL. Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis. Semin Reprod Endocrinol. 1996;14:247-255.
15. Tseng J, Ryan I, Milam T, et al. Interleukin 6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. JCEM. 1996;81:1118-1122.
16. Wu Y, Kajdacsy-Balla A, Strawn E, et al. Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology. 2006;147:232-246. (Pubitemid 43004277)
17. Redwine DB. Was Sampson wrong? Fertil Steril. 2002;78:686-693.
18. Grummer R. Animal models in endometriosis research. Hum Reprod Update. 2006;12:641-649.
19. Maas JW, Groothuis PG, Dunselman GA, et al. Development of endometriosis-like lesions after transplantation of human endometrial fragments onto the chick embryo chorioallantoic membrane. Hum Reprod. 2001;16:627-631.
20. Scher C, Haudenschild C, Klagsbrun M. The chick chorioallantoic membrane as a model system for the study of tissue invasion by viral transformed cells. Cell. 1976;8:373-382.
21. Giannopoulou E, Katsoris P, Hatziapostolou M, et al. X-rays modulate extracellular matrix in vivo. Int J Cancer. 2001;94:690-698.
22. Nap AW, Groothuis PG, Demir AY, et al. Tissue integrity isessential for ectopic implantation of human endometrium in the chicken chorioallantoic membrane. Hum Reprod. 2003;18:30-34.
23. Oosterlynck DJ, Meuleman C, Waer M, et al. Immunosuppressive activity of peritoneal fluid in women with endometriosis. Obstet Gynecol. 1993;82:206-212. (Pubitemid 23217659)
24. Liotta LA, Lee CW, Morakis DJ. New method for preparing large surfaces of intact human basement membrane for tumor invasion studies. Cancer Lett. 1980;11:141-152.
25. Van der Linden PJ, de Goeij AF, Dunselman GA, et al. Endometrial cell adhesion in an in vitro model using intact amniotic membranes [see comment]. Fertil Steril. 1996;65:76-80.
26. Santini MT, Rainaldi G, Indovina PL. Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Crit Rev Oncol Hematol. 2000;36:75-87.
27. Kobayashi H. Invasive capacity of heterotopic endometrium. Gynecol Obstet Invest. 2000;50 (suppl 1) : 26-32.
28. Fasciani A, Bocci G, Xu J, et al. Threedimensional in vitro culture of endometrial explants mimics the early stages of endometriosis. Fertil Steril. 2003;80:1137-1143.
29. Te Linde RW, Scott RB. Experimental endometriosis. Am J Obstet Gynecol. 1950;60:1147-1173.
30. D'Hooghe TM, Kyama CM, Chai D, et al. Nonhuman primate models for translational research in endometriosis. Reprod Sci. 2009;16:152-161.
31. D'Hooghe TM, DebrockS, Meuleman C, et al. Future directions in endometriosis research. Obstet Gynecol Clin N Am. 2003;30:221-244.
32. D'Hooghe TM, Bambra CS, Raeymaekers BM, et al. A prospective controlled study over 2 years shows a normal monthly fertility rate (MFR) in baboons with stage I endometriosis and a decreased MFR in primates with stage II and stage III-IV disease. Fertil Steril. 1996;66:809-813.
33. Giudice LC. Genomics' role in understanding the pathogenesis of endometriosis. Semin Reprod Med. 2003;21:119-124.
34. Taylor RN, Lundeen SG, Giudice LC. Emerging role of genomics in endometriosis research. Fertil Steril. 2002;78:694-698.
35. Taylor HS. Endometrial cells derived from donor stem cells in bone marrow transplant recipients [see comment]. JAMA. 2004;292:81-85.
36. Miltiadis P, Kanakas N. The role of matrix metalloproteinases in the pathogenesis of endometriosis. Reprod Sci. 2009;16:717-726.
37. McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today. 2000;6:149-156.
38. Uzan C, Cortez A, Dufournet C, et al. Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2,-3 and-11, and of tissue inhibitor metalloproteinases-1 and-2. Virchows Arch. 2004;445:603-609.
39. Gupta S, Goldberg JM, Aziz N, et al. Pathogenic mechanisms in endometriosisassociated infertility. Fertil Steril. 2008;90:247-257.
40. Groothuis PG, Koks CA, de Goeij AF, et al. Adhesion of human endometrial fragments to peritoneum in vitro. Fertil Steril. 1999;71:1119-1124.
41. Koks CA, Groothuis PG, Dunselman GA, et al. Adhesion of menstrual endometrium to extracellular matrix: the possible role of integrin alpha (6) beta (1) and laminin interaction. Mol Hum Reprod. 2000;6:170-177.
42. Dechaud H, Witz CA, Montoya-Rodriguez IA, et al. Mesothelial cell-associated hyaluronic acid promotes adhesion of endometrial cells to mesothelium. Fertil Steril. 2001;76:1012-1018.
43. Gaetje R, Kotzian S, Herrmann G, et al. Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin. Am J Pathol. 1997;150:461-467.
44. Witz CA, Cho S, Centonze VE, et al. Time series analysis of transmesothelial invasion by endometrial stromal and epithelial cells using three-dimensional confocal microscopy. Fertil Steril. 2003;79 (suppl 1) : 770-778.
45. Nair AS, Nair HB, Lucidi RS, et al. Modeling the early endometriotic lesion: mesothelium-endometrial cell co-culture increases endometrial invasion and alters mesothelial and endometrial gene transcription. Fertil Steril. 2008;90:1487-1495.
46. Siristatidis C, Nissotakis C, Chrelias C, et al. Immunological factors and their role in the genesis and development of endometriosis. J Obstet Gynaecol Res. 2006;32:162-170.
47. Braun DP, Gebel H, Rotman C, et al. The development of cytotoxicity in peritoneal macrophages from women with endometriosis. Fertil Steril. 1992;57:1203-1210.
48. Nothnick WB, Curry TE, Vernon MW. Immunomodulation of rat endometriotic implant growth and protein production. Am J Reprod Immunol. 1994;31:151-162.
49. Altintas D, Kokcu A, Kandemir B, et al. Efficacy of imiquimod, an immunomodulatory agent, on experimental endometriosis. Fertil Steril. 2008;90:401-405. (Pubitemid 352040701)
50. Dmowski WP, Steele RW, Baker GF. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol. 1981;141:377-383.
51. Steele RW, Dmowski WP, Marmer DJ. Immunologic aspects of human endometriosis. Am J Reprod Immunol. 1984;6:33-36.
52. Oosterlynck DJ, Cornillie FJ, Waer M, et al. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril. 1991;56:45-51.
53. Garzetti GG, Ciavattini A, Provinciali M, et al. Natural killer cell activity in endometriosis: correlation between serum estradiol levels and cytotoxicity. Obstet Gynecol. 1993;81:665-668.
54. Bruner-Tran KL, Yeaman GR, Crispens MA, et al. Dioxin may promote inflammation-related development of endometriosis. Fertil Steril. 2008;89:1287-1298.
55. Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol. 2001;169:453-459. (Pubitemid 32536978)
56. Panigrahy D, Kaipainen A, Huang S, et al. PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition. Proc Natl Acad Sci U S A. 2008;105:985-990.
57. Varet J, Vincent L, Mirshahi P, et al. Fenofibrate inhibits angiogenesis in vitro and in vivo. Cell Mol Life Sci. 2003;60:810-819.
58. Onalan G, Zeyneloglu HB, Bayraktar N. Fenofibrate causes regression of endometriotic implants: a rat model. Fertil Steril. 2009;92:2100-2102.
59. Oktem M, Esinler I, Eroglu D, et al. Highdose atorvastatin causes regression of endometriotic implants: a rat model. Hum Reprod. 2007;22:1474-1480. (Pubitemid 47062821)
60. Donnez J, Smoes P, Gillerot S, et al. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod. 1998;13:1686-1690.
61. Nap AW, Dunselman GAJ, Griffioen AW, et al. Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane. Fertil Steril. 2005;83:793-795.
62. Tamura M, Sebastian S, Gurates B, et al. Vascular endothelial growth factor upregulates cyclooxygenase-2 expression in human endothelial cells. J Clin Endocrinol Metab. 2002;87:3504-3507.
63. Jabbour HN, Sales KJ, Smith OPM, et al. Prostaglandin receptors are mediators of vascular function in endometrial pathologies. Mol Cell Endocrinol. 2006;252:191-200.
64. Olive DL, Pritts EA. Treatment of endometriosis. N Engl J Med. 2001;345:266-275.
65. Soysal S, Soysal ME, Ozer S, et al. The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod. 2004;19:160-167.